In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months. A ...

You were just another C.T.R.L. employee clocking the graveyard shift, filing reports on things that shouldn’t exist. Now, the facility is under a sudden, total lockdown. Your main objective? Survive ...